Stock A060590 CTCBIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News CTCBIO Inc.

Equities

A060590

KR7060590007

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
8,030 KRW +1.01% Intraday chart for CTCBIO Inc. -0.99% -24.95%
05-14 CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-24 Korean Sugar Imports Plunge 14% as Diabetes Cases Surge MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Korean Sugar Imports Plunge 14% as Diabetes Cases Surge
MT
CTCBIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
An unknown buyer agreed to acquire an unknown minority stake in CTCBIO Inc. for KRW 20 billion.
CI
CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
An unknown buyer agreed to acquire 12.57229% stake in CTCBIO Inc. for KRW30 billion.
CI
CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CI
CTCBIO Inc. announced that it expects to receive KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.
CI
CTCBIO Inc. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
CI
CTCBIO Inc. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd
CI
CTCBIO Inc. announced that it has received KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp.
CI
CTCBIO Inc. announced that it expects to receive KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp. other investors
CI
CTCBIO Inc. announced that it has received KRW 20 billion in funding from Korea Investment Partners Co. Ltd.
CI
CTCBIO Inc. announced that it expects to receive KRW 20 billion in funding from Korea Investment Partners Co. Ltd. and other investors
CI
CTCBIO., Inc.'s Equity Buyback announced on August 8, 2014 has expired.
CI
CTCBIO., Inc.(KOSDAQ:A060590) added to Russell Global Index
CI
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology from CTCBIO Inc
CI
CTCBIO., Inc.'s Equity Buyback Plan Extended till August 4, 2015.
CI
CTCBIO., Inc. cancelled the acquisition of a Factory in Ansan City from SK Chemicals Ltd.
CI
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 8, 2014.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A060590 Stock
  4. News CTCBIO Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW